A Study to Investigate the Effect on Lung Function of BDA Formulated With a Next Generation Propellant Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma
Clinical trial NCT06502366 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06502366
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-22
- Primary completion
- 2026-03-03
- Enrollment
- 422
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.